Chronic Benzodiazepine Use in Nursing Homes: Effects of Federal Guidelines, Resident Mix, and Nurse Staffing
- 1 December 2001
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 49 (12) , 1673-1678
Abstract
To assess the overall prescribing and chronic use of benzodiazepines (BZs) in nursing homes before and after implementation of BZ guidelines by the Health Care Finance Administration (HCFA). A second aim was to identify facility predictors of BZ prescribing and chronic use after guideline implementation. Nonexperimental, observational study design. Drug use was assessed in 16 randomly selected skilled nursing facilities in Wisconsin before 1990 and again in 1993-1994. One thousand one hundred eighty-one Medicaid-funded residents at baseline and 1,650 Medicaid-funded residents at follow-up. Drug use measures included percentage of residents with prescribed BZs and percentage of residents with chronic BZ use (defined as >or=4 months of continuous use). A 4-month cutoff was used because HCFA guidelines consider this length of continuous use to be potentially excessive. Facility predictors of drug use included resident demographic and diagnostic mix, size, ownership, Medicaid per diem, and nurse staffing. Before 1990, one-fourth of all residents were prescribed a BZ and nearly one-tenth of all residents had chronic BZ use. Federal guidelines had nonsignificant effects on these measures; BZ prescribing declined only 3.6% (26.4-22.8%) and chronic use declined only 1.3% (9.2-7.9%). Regression results showed that overall prescribing at follow-up was higher in facilities with more female residents (beta= .52, P= .018) and residents with psychiatric disorders (beta= .41, P= .045). However, nurse staffing was the only significant predictor of chronic BZ use. As expected, better nurse staffing was associated with lower rates of chronic use (beta= -0.46, P= .037). Efforts to improve BZ use in nursing homes must address the need for better nurse staffing and better assessment and management of psychiatric disorders that can trigger BZ prescribing.Keywords
This publication has 21 references indexed in Scilit:
- Variations in the Treatment Culture of Nursing Homes and Responses to Regulations to Reduce Drug UsePsychiatric Services, 2001
- Changes in Resident and Facility Risk Factors for Psychotropic Drug Use in Nursing Homes Since the Nursing Home Reform ActJournal of Applied Gerontology, 1999
- Benzodiazepine use and cognitive function among community-dwelling elderly*Clinical Pharmacology & Therapeutics, 1998
- The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.American Journal of Public Health, 1995
- Anxiolytic and Sedative/Hypnotic Unnecessary Drug Use EvaluationJournal of Geriatric Drug Therapy, 1994
- Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations1994
- Nursing Home Responsiveness to Research Requests: Results of a Field StudyThe Gerontologist, 1992
- Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residentsInternational Journal of Geriatric Psychiatry, 1992
- Dr. Schweizer and Associates ReplyAmerican Journal of Psychiatry, 1989
- Psychotropic Drug Practice In Nursing HomesJournal of the American Geriatrics Society, 1988